The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

I had been taking Zepbound for about six months when it clicked. My period — the monster that turned me from a functioning ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

An estimated 39 million American adults suffer from obstructive sleep apnea, a condition in which the upper airway is blocked while sleeping.

For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food and Drug Administration on ...